Cross Country Healthcare, Inc.

Historical 13F Holders

Symbol
CCRN
CUSIP
227483104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 227483104 since 12/18/2024, largest first.

Filer % of Class Filed
Boston Partners 13G 7.9% 5/14/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.5% 7/16/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Dimensional Fund Advisors LP 13G/A 5.0%
Checked 5% or less
4/9/2026
Event 3/31/2026
Magnetar Financial LLC 13D/A
4.98% 12/10/2025
Event 12/8/2025
Goldman Sachs Group Inc 13G/A
3.9% 11/12/2025
Event 9/30/2025
AllianceBernstein L.P. 13G/A 0.1% 2/17/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 157 29.4 M $388 M
2026 Q1 158 28.4 M $267 M
2025 Q4 163 26.1 M $211 M
2025 Q3 181 32.0 M $455 M
2025 Q2 172 31.8 M $415 M
2025 Q1 170 32.9 M $490 M
2024 Q4 181 31.8 M $577 M
2024 Q3 186 34.8 M $471 M
2024 Q2 170 35.2 M $487 M
2024 Q1 186 37.1 M $694 M
2023 Q4 184 38.1 M $863 M
2023 Q3 196 37.1 M $921 M
2023 Q2 204 37.1 M $1.04 B
2023 Q1 209 37.8 M $845 M
2022 Q4 243 37.2 M $988 M
2022 Q3 211 36.6 M $1.04 B
2022 Q2 190 36.2 M $757 M
2022 Q1 210 35.5 M $772 M
2021 Q4 194 34.1 M $950 M
2021 Q3 171 34.4 M $729 M
2021 Q2 160 34.1 M $564 M
2021 Q1 132 34.1 M $425 M
2020 Q4 130 35.2 M $312 M
2020 Q3 124 34.0 M $221 M
2020 Q2 128 34.2 M $211 M
2020 Q1 146 35.5 M $239 M
2019 Q4 141 35.8 M $416 M
2019 Q3 135 35.1 M $361 M
2019 Q2 125 35.0 M $327 M
2019 Q1 136 35.3 M $248 M
2018 Q4 151 33.0 M $242 M
2018 Q3 139 34.0 M $297 M
2018 Q2 143 33.3 M $374 M
2018 Q1 136 35.6 M $395 M
2017 Q4 147 34.5 M $441 M
2017 Q3 158 33.6 M $478 M
2017 Q2 148 34.9 M $450 M
2017 Q1 158 34.1 M $489 M
2016 Q4 163 32.5 M $507 M
2016 Q3 153 32.5 M $382 M
2016 Q2 154 31.8 M $443 M
2016 Q1 158 32.2 M $374 M
2015 Q4 175 31.9 M $523 M
2015 Q3 146 30.5 M $415 M
2015 Q2 129 30.1 M $381 M
2015 Q1 129 30.6 M $364 M
2014 Q4 129 29.8 M $371 M
2014 Q3 132 31.2 M $290 M
2014 Q2 124 29.3 M $191 M
2014 Q1 125 30.0 M $241 M